文献速递心血管MR

非梗阻性肥厚型心肌病患者与竞技运动员的1H和31P心肌磁共振波谱研究

1H- and 31P-myocardial magnetic resonance spectroscopy in non-obstructive hypertrophic cardiomyopathy patients and competitive athletes.
PubMed 文献 · Radiol Med · 2017-01-09

前瞻性纳入15名竞技运动员与7例非梗阻性肥厚型心肌病患者,行1.5T心脏磁共振、单体素1H-MRS和多体素31P-MRS,患者心肌总脂质显著高于运动员,而PCr/γATP比值两组间无显著差异。

要点

  • 非梗阻性肥厚型心肌病患者心肌总脂质中位数763 au,显著高于竞技运动员的35 au(P=0.046)。
  • 两组PCr/γATP比值分别为运动员5、患者4,差异无统计学意义(P=0.230)。
  • 室间隔厚度患者18 mm显著大于运动员10 mm(P=0.003),可辅助鉴别。

核心结论

  • 与竞技运动员相比,非梗阻性肥厚型心肌病患者心肌脂质显著增高,但PCr/γATP比值保持。

研究设计与样本

  • 前瞻性研究,纳入15名竞技运动员和7例非梗阻性肥厚型心肌病患者,行1.5T心脏磁共振(心电触发电影成像、单体素1H-MRS、多体素31P-MRS),1H-MRS用标准线圈仰卧位,31P-MRS用专用线圈俯卧位,数据以中位数和四分位距表示,采用Mann-Whitney U检验。

关键影像表现/征象

  • 运动员左室质量指数72(66-83)g/m2,患者81(76-111)g/m2(P=0.052)。
  • 运动员室间隔厚度10(10-11)mm,患者18(15-21)mm(P=0.003)。
  • 运动员舒张末期容积指数95(85-102)ml/m2,患者73(58-76)ml/m2(P=0.029)。
  • 运动员收缩末期容积指数30(28-32)ml/m2,患者20(16-34)ml/m2(P=0.274)。
  • 运动员射血分数68%(65-69%),患者68%(55-73%)(P=1.000)。

诊断标准与关键数值

  • 1H-MRS总脂质:运动员35(0-183)au,患者763(155-1994)au(P=0.046)。
  • 31P-MRS PCr/γATP:运动员5(4-6)au,患者4(2-5)au(P=0.230)。

临床应用与阅片要点

  • 1H-MRS测得心肌总脂质显著升高(患者中位数763 au vs 运动员35 au,P=0.046),可能有助于鉴别非梗阻性肥厚型心肌病与运动员心脏。
  • 31P-MRS的PCr/γATP比值在两组间无显著差异(患者中位数4 vs 运动员5,P=0.230)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: The clinical differentiation between athlete's heart and mild forms of non-obstructive hypertrophic cardiomyopathy (HCM) is crucial. We hypothesized that differences do exist between the myocardial metabolism of patients with non-obstructive HCM and competitive athletes (CAs). Our aim was to evaluate myocardial metabolism with 31P-MRS and 1H-MRS in HCM patients and CAs.

MATERIALS AND METHODS: After Ethics Committee approval, 15 CAs and 7 HCM patients were prospectively enrolled. They underwent a 1.5-T cardiac MR including electrocardiographically triggered cine images, single-voxel 1H-MRS and multivoxel 31P-MRS. 1H-MRS was performed after imaging using standard coil with the patient in the supine position; thereafter, 31P-MRS was performed using a dedicated coil, in the prone position. Data were reported as median and interquartile range. Mann-Whitney U test was used.

RESULTS: In CAs, left ventricular mass index was 72 (66-83) g/m2, septal thickness 10 (10-11) mm, end diastolic volume index 95 (85-102) ml/m2, end systolic volume index 30 (28-32) ml/m2 and ejection fraction 68% (65-69%); in HCM patients, 81 (76-111) g/m2 (P = 0.052), 18 (15-21) mm (P = 0.003), 73 (58-76) ml/m2 (P = 0.029), 20 (16-34) ml/m2 (P = 0.274) and 68% (55-73%) (P = 1.000), respectively. At 1H-MRS, total lipids were 35 (0-183) arbitrary units (au) for CA and 763 (155-1994) au for HCM patients (P = 0.046). At 31P-MRS, PCr/γATP was 5 (4-6) au for CA and 4 (2-5) au for HCM patients (P = 0.230). Examination time was 20 min for imaging only, 5 min for 1H-MRS and 15 min for 31P-MRS.

CONCLUSIONS: We observed a significant increase of myocardial lipids, but a preserved PCr/γATP ratio in the metabolism of HCM patients compared with competitive CAs.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Secchi F, Di Leo G, Petrini M, et al. 1H- and 31P-myocardial magnetic resonance spectroscopy in non-obstructive hypertrophic cardiomyopathy patients and competitive athletes. Radiol Med. 2017. PMID: 28070839. doi:10.1007/s11547-016-0718-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。